Evidence map›Paper›PMID 19576786›Full record

ArticleBioorganic & medicinal chemistry2009

Identification, structure-activity relationships and molecular modeling of potent triamine and piperazine opioid ligands.

Austin B Yongye, Jon R Appel, Marc A Giulianotti, Colette T Dooley, Jose L Medina-Franco, Adel Nefzi, Richard A Houghten, Karina Martínez-Mayorga

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Austin B YongyeTorrey Pines Institute for Molecular Studies, 11350 SW Village Parkway, Room 132, Port St. Lucie, FL 34987, USA.
Jon R Appel
Marc A Giulianotti
Colette T Dooley
Jose L Medina-Franco
Adel Nefzi
Richard A Houghten
Karina Martínez-Mayorga
Torrey Pines Institute For Molecular Studies · USGeneral Atomics (United States) · US

Funding

IDENTIFICATION OF RECEPTOR SPECIFIC OPIOID LIGANDSR01DA009410 · NIDA · TORREY PINES INST FOR MOLECULAR STUDIES · PI HOUGHTEN, RICHARD A · 1995 to 2002
$855k
NIDA NIH HHS DA09410NIDA NIH HHS R01 DA009410
6 · The paper itself

Abstract

Opioid receptors are important targets for pain management. Here, we report the synthesis and biological evaluation of three positional scanning combinatorial libraries, consisting of linear triamines and piperazines. A highly potent (14 nM) and selective (IC(50(mu))/IC(50(kappa))=71; IC(50(delta))/IC(50(kappa))=714) triamine for the kappa-opioid receptor was found. In addition, non-selective mu-kappa binders were obtained, with binding affinities of 54 nM and 22 nM for mu- and kappa-opioid receptors, respectively. Structure-activity relationships of each subset are described. 3D molecular alignments based on shape similarity to internal and external query molecules were carried out. For the combinatorial chemistry dataset studied here a 1.3 similarity cut-off value was observed to be efficient in the rocs-based alignment method. Interactions from the overlays analyzed in the binding sites of homology models of the receptors revealed specific substitution patterns for enhancing binding affinity in the piperazine series. Pharmacophore modeling of the compounds found from the three combinatorial libraries was also performed. The pharmacophore model indicated that the important feature for receptor binding activity with the mu-receptor was the presence of at least one hydrogen bond acceptor and one aromatic hydrophobic group. Whereas for the kappa-receptor two binding modes emerged with one set of compounds employing the hydrogen bond acceptor and aromatic hydrophobic group, and a second set possibly via interactions with the receptor by hydrophobic and ionic salt-bridges.

Indexed as

Binding SitesModels, MolecularMolecular ConformationPiperazinePiperazinesPolyaminesProtein BindingReceptors, OpioidReceptors, Opioid, kappaReceptors, Opioid, muStructure-Activity RelationshipPiperazinePiperazinesPolyaminesReceptors, OpioidReceptors, Opioid, kappaReceptors, Opioid, mu

Identifiers

PMID19576786
PMCPMC2746904
OpenAlexW2015121964

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.